IDEXX Laboratories (IDXX) vs Mettler-Toledo International (MTD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Mettler-Toledo International (MTD) has outperformed IDEXX Laboratories (IDXX) over the past year, gaining 17.1% versus a loss of 19.2%. Over five years, MTD leads with a +8.2% price change compared with -19.2% for IDXX. IDEXX Laboratories is the larger company by market cap ($40.43 billion vs $30.65 billion), about 1.3 times the size.
On valuation, Mettler-Toledo International trades at a lower forward P/E (29.5x vs 30.7x for IDEXX Laboratories). IDEXX Laboratories converts more of its revenue into profit, with a net margin of 24.6% versus 21.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IDXX | MTD |
|---|---|---|
| Share price | $513.14 | $1,529.46 |
| Market cap | $40.43B | $30.65B |
| 1-day change | +1.28% | -0.26% |
| YTD return | -25.11% | +9.99% |
| 1-year return | -19.23% | +17.14% |
| 5-year return | -19.21% | +8.16% |
| P/E ratio (TTM) | 36.06 | 34.47 |
| Forward P/E | 30.66 | 29.55 |
| EPS (TTM) | $14.23 | $44.37 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $4.30B | $4.03B |
| Revenue growth (YoY) | +10.42% | +3.98% |
| Net income (latest FY) | $1.06B | $869.19M |
| Gross margin | 61.80% | 59.37% |
| Operating margin | 31.60% | — |
| Net margin | 24.62% | 21.59% |
| 52-week high | $769.98 | $1,585.72 |
| 52-week low | $500.61 | $1,023.05 |
| Distance from 52-week high | -33.36% | -3.55% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +36.67% | -3.79% |
| Average volume | 553.95K | 186.49K |
| Shares outstanding | 78.78M | 20.04M |
| Employees | 11,000 | 16,600 |
| Sector | Health Care | Industrials |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MTD has outperformed IDXX by 36.4 percentage points over the past year.
- IDEXX Laboratories grew revenue faster in its latest fiscal year (+10.42% vs +3.98%).
- The two companies sit in different sectors: IDEXX Laboratories in Health Care and Mettler-Toledo International in Industrials.
About IDEXX Laboratories
IDXX stock →IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 11,000 employees
About Mettler-Toledo International
MTD stock →Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.
Industrials · Biotechnology: Laboratory Analytical Instruments · 16,600 employees
IDXX vs MTD FAQ
Which is bigger, IDEXX Laboratories or Mettler-Toledo International?
IDEXX Laboratories (IDXX) is larger, with a market capitalization of $40.43B compared with $30.65B for Mettler-Toledo International (MTD).
Which stock has performed better over the past year, IDXX or MTD?
MTD returned +17.14% over the past 12 months, compared with -19.23% for IDXX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, IDXX or MTD?
MTD has the lower trailing P/E at 34.5, versus 36.1 for IDXX. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are IDEXX Laboratories and Mettler-Toledo International in the same industry?
No. IDEXX Laboratories is in the Health Care sector, while Mettler-Toledo International is in Industrials.